Pembrolizumab for melanoma- safety profile and future trends

Expert Opin Drug Saf. 2016 Jun;15(6):727-9. doi: 10.1080/14740338.2016.1175430. Epub 2016 Apr 27.
No abstract available

Keywords: Melanoma; PD-1; cancer immunotherapy; pembrolizumab; safety.

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Melanoma / drug therapy*
  • Skin Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • pembrolizumab